Rexahn: Farmington Hills biotech company Ocuphire strikes deal that will put it on stock exchange

Farmington Hills biotech company Ocuphire Pharma Inc. last week announced it had a reached a definitive agreement to merge with Rexahn Pharmaceuticals Inc. (NasdaqCM: REXN) of Rockville, Md., in a deal that would result in Ocuphire becoming publicly traded.The all-stock deal, expected to close in...